CVMCX
Price
$16.85
Change
+$0.02 (+0.12%)
Updated
Sep 20 closing price
FNWFX
Price
$83.10
Change
-$0.10 (-0.12%)
Updated
Sep 20 closing price
Ad is loading...

CVMCX vs FNWFX

Header iconCVMCX vs FNWFX Comparison
Open Charts CVMCX vs FNWFXBanner chart's image
Calvert Emerging Markets Equity C
Price$16.85
Change+$0.02 (+0.12%)
VolumeN/A
CapitalizationN/A
American Funds New World F3
Price$83.10
Change-$0.10 (-0.12%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CVMCX vs FNWFX Comparison Chart
Loading...
VS
CVMCX vs. FNWFX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVMCX is a StrongBuy and FNWFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 63.1B vs. CVMCX (1.52B). FNWFX pays higher dividends than CVMCX: FNWFX (1.56) vs CVMCX (0.00). CVMCX was incepted earlier than FNWFX: CVMCX (12 years) vs FNWFX (8 years). CVMCX is a more actively managed with annual turnover of: 59.00 vs. FNWFX (32.00). CVMCX has a lower initial minimum investment than FNWFX: CVMCX (1000) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 18.70 vs. CVMCX (15.33). FNWFX return over 5 years is better than : 25.74 vs. CVMCX (6.24).
CVMCXFNWFXCVMCX / FNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years8 years-
Gain YTD8.08210.80075%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.52B63.1B2%
Annual Yield % from dividends0.001.56-
Returns for 1 year15.3318.7082%
Returns for 3 years-17.32-9.66179%
Returns for 5 years6.2425.7424%
Returns for 10 years26.78N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTNX60.821.83
+3.10%
Nutanix
DMAC4.130.09
+2.23%
DiaMedica Therapeutics
BNL18.73-0.03
-0.16%
Broadstone Net Lease
CATX13.23-0.24
-1.78%
Perspective Therapeutics
CLWT1.63-0.06
-3.55%
Euro Tech Holdings Company Limited